UPC
Universe Pharmaceuticals Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.03
P/S
0.09
EV/EBITDA
7.76
DCF Value
$6,872.26
FCF Yield
-322.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
35.3%
Operating Margin
-16.3%
Net Margin
-20.6%
ROE
-6.6%
ROA
-5.3%
ROIC
-4.5%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $8.7M | $-387.3K | $-0.69 |
| FY 2025 | $17.9M | $-3.7M | $-1,055.75 |
| Q2 2025 | $9.2M | $-3.3M | $-944.40 |
| Q4 2024 | $10.1M | $4.4M | $719.79 |
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
CN
Exchange
NASDAQ
Beta
1.48
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.